Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (25578)	9/21/1998 5:09:00 PM
From: Wallace Rivers	Read Replies (3) \| Respond to of 32384

*OT*It would also be interesting if you had mentioned all the trades labelled "frmT", rather you chose to mention only the two high tick trades of 400 shares each - yielding a whopping 800 shares of volume. You failed to mention the 12,800 shares (labelled "frmT") which traded below the top tick at prices of 7 3/4-7 7/8, 11,300 shares of which were bid side 7 3/4. Not that any of the above is of anything but minimal interest Why do you even bring these facts up? It seems you rarely comment about price action, except when LGND goes up. And thanks for your kind reminder about a little disagreement we had, when you mentioned we might "hear more about "out of sequence trades"." By that mention, it seems that you are largely ignoring Cheryl's truce request. You have diverted my attention from what I see in LGND price action today, which is IMHO bouncing very nicely from a severely oversold condition. Stick to your discussion on LGND science. Your delving into the minutiae of trading tends to be biased, unnecessary, and irrelevant.